DaVita Inc. (DVA) Cash Flow Statement

The gap between net income and operating cash flow is consistently positive, which may indicate that reported earnings understate cash generation in the near term. However, the magnitude of the swings, particularly the 5.60x reading in 2025Q3 driven by a $253.3 million working capital inflow, suggests the conversion ratio is not a reliable run-rate indicator. Investors should monitor whether conversion normalizes toward a lower band as working capital reverses.

The recent recovery in free cash flow appears to be a partial rebound from a weak 2025Q1 trough rather than a return to prior peaks. Free cash flow of $359.3 million in 2026Q3 is supported by operating cash flow of $518.8 million, yet the margin gap versus 2024 suggests either working capital absorption or structurally lower cash yield per dollar of revenue. This may warrant further investigation into whether the 2024 peak reflected unsustainable working capital tailwinds.

Repurchase volume has been heavy relative to quarterly free cash flow, with buybacks exceeding free cash flow in several quarters including 2025Q4 and 2026Q1. This pattern suggests the company may be funding part of its repurchase program from balance sheet capacity or incremental borrowing, consistent with the strained leverage profile. Investors should monitor whether buyback pace remains sustainable if operating cash flow softens.

Working capital movements account for much of the variance between net income and operating cash flow, which suggests collection timing and payables management are key drivers of cash results. The pattern of large inflows in the third quarter followed by outflows in early-year quarters may reflect seasonal billing and collection cycles typical of government-reimbursed dialysis services. Analysts should treat single-quarter cash figures with caution and focus on trailing cumulative trends.